Equities

CorVel Corp

CRVL:NSQ

CorVel Corp

Actions
Health CareHealth Care Providers
  • Price (USD)284.31
  • Today's Change3.14 / 1.12%
  • Shares traded34.97k
  • 1 Year change+38.70%
  • Beta1.0902
Data delayed at least 15 minutes, as of Jul 19 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CorVel Corporation applies technology including artificial intelligence, machine learning and natural language processing to enhance the management of episodes of care and the related health care costs. The Company partners with employers, third-party administrators, insurance companies and government agencies in managing workers' compensation and health, auto and liability services. Its customized services, delivered locally, are backed by a national team to support clients as well as their customers and patients. The Company's services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care and Medicare services. The Company offers a complete medical savings solution for all in-network and out-of-network medical bills. Its bill review services include coding review and re-bundling, reasonable and customary review, fee schedule analysis, preferred provider organization management, and repricing.

  • Revenue in USD (TTM)795.31m
  • Net income in USD76.25m
  • Incorporated1991
  • Employees4.87k
  • Location
    CorVel CorpSUITE 1020, 2010 MAIN STREEIRVINE 92614United StatesUSA
  • Phone+1 (949) 851-1473
  • Fax+1 (949) 851-1469
  • Websitehttps://www.corvel.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Progyny Inc1.11bn61.26m2.82bn563.0048.724.9744.212.540.60710.607110.985.951.53--3.631,968,529.008.4811.5011.8816.0221.8921.485.536.64----0.000.0038.3459.52104.35--44.47--
Astrana Health Inc1.45bn62.42m2.85bn1.80k38.353.6935.221.961.321.3230.8513.771.31--8.64807,652.305.617.096.619.3916.5818.304.286.36--61.710.463510.5421.1921.6834.4241.1689.42--
Agilon Health Inc4.78bn-207.85m3.03bn1.12k--4.39--0.6335-0.5182-0.7111.781.682.13--3.714,283,411.00-9.27---20.91--6.37---4.35------0.0514--80.74---112.01------
Amedisys Inc2.25bn-20.59m3.19bn19.00k--2.941,050.711.42-0.6446-0.644668.7333.301.12--6.89118,495.10-1.057.82-1.3810.3944.3943.63-0.94395.89--11.620.25610.000.5936.11-108.22--14.16--
Surgery Partners Inc2.79bn600.00k3.76bn10.50k9,720.401.9113.581.340.0030.00322.1415.480.410427.435.90266,142.802.331.173.201.6326.9726.335.673.031.562.470.4606--8.039.1478.21--17.41--
Sotera Health Co1.08bn54.57m3.78bn3.00k69.338.8016.473.510.19260.19263.811.520.33279.878.36358,958.001.69-0.8681.92-0.966455.0554.405.09-2.682.862.350.8439--4.547.06121.87--24.24--
Radnet Inc1.66bn21.27m4.60bn7.87k191.895.2825.662.780.32480.324824.8311.810.6159--7.88210,591.101.861.242.391.6621.9321.563.021.86--1.730.43650.0013.0510.64-71.42-37.6319.60--
Hims & Hers Health Inc959.40m-2.35m4.72bn1.05k--13.69586.874.92-0.0145-0.01454.461.612.336.68176.36917,209.40-0.5704---0.6968--82.41---0.245--2.48--0.00--65.49--64.15------
CorVel Corp795.31m76.25m4.89bn4.87k64.8419.7147.726.154.404.4045.8514.461.87--8.93163,308.2017.9714.8730.7324.2121.5922.149.599.16----0.000.0010.685.9514.9010.5713.87--
PACS Group Inc-100.00bn-100.00bn5.06bn32.43k--38.31----------0.8661----------------------------0.8608--28.47---25.00------
Select Medical Holdings Corp6.79bn259.99m5.10bn38.40k18.813.689.410.75172.092.0954.6210.650.8726--6.37176,767.904.264.195.265.4614.4413.984.895.11--3.780.697815.305.225.5753.0311.986.50--
Option Care Health Inc4.43bn272.67m5.37bn5.81k20.313.7516.021.211.521.5224.808.221.3914.009.15763,044.908.553.6310.644.3522.3522.456.152.781.396.980.42640.009.0643.4277.40--24.72--
R1 Rcm Inc2.31bn-33.40m5.49bn29.40k--1.9421.382.37-0.0799-0.07995.296.710.4263--6.1678,656.46-0.61571.35-0.65881.5320.7520.09-1.441.96--1.770.4468--24.7921.02105.21--25.07--
Acadia Healthcare Company Inc2.99bn-11.30m6.24bn23.50k--2.1546.662.08-0.1354-0.135432.7131.300.5667--8.17176,030.70-0.06532.32-0.07262.64-----0.11535.601.255.860.3843--12.208.99-107.93--3.34--
Data as of Jul 19 2024. Currency figures normalised to CorVel Corp's reporting currency: US Dollar USD

Institutional shareholders

39.76%Per cent of shares held by top holders
HolderShares% Held
Kayne Anderson Rudnick Investment Management LLCas of 31 Mar 20241.90m11.09%
BlackRock Fund Advisorsas of 31 Mar 20241.30m7.59%
The Vanguard Group, Inc.as of 31 Mar 20241.09m6.34%
Renaissance Technologies LLCas of 31 Mar 2024670.31k3.91%
Dimensional Fund Advisors LPas of 31 Mar 2024552.06k3.22%
SSgA Funds Management, Inc.as of 31 Mar 2024352.91k2.06%
Neuberger Berman Investment Advisers LLCas of 31 Mar 2024272.85k1.59%
Boston Trust Walden, Inc.as of 30 Jun 2024242.54k1.41%
Geode Capital Management LLCas of 31 Mar 2024229.60k1.34%
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 2024207.86k1.21%
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.